Re: Intravesical interleukin-2 in T1 papillary bladder carcinoma: regression of marker lesion in 8 of 10 patients.
Atan
A
A
Basar
M M
MM
D000283:Administration, Intravesical; D002291:Carcinoma, Papillary / Q000188:drug therapy* / Q000473:pathology*; D006801:Humans; D007376:Interleukin-2 / Q000008:administration & dosage*; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000473:pathology*
D007376:Interleukin-2